However, the activation of SIRT3 can inhibit cardiomyocyte apoptosis and alleviate cardiac fibrosis by reducing ROS, enhancing the activities of antioxidant enzymes such as SOD2, and improving mitochondrial function [31]. The gene discussed is SIRT3; the disease is fibrosis.